Revenues stood at £2.92bil (US$3.64bil) for the quarter ended March 31. — Reuters
NEW YORK: Consumer healthcare company Haleon has reported first-quarter revenue slightly below market estimates, as volumes declined due to retailer destocking in the United States and cooling demand for some of its medicines after a surge last year.
The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil’s sales in Canada, following a surge in demand last year.
